Search results for "Intestin"

showing 10 items of 2215 documents

Intestinal filtration as a consequence of increased mucosal hydraulic permeability

1980

Two mechanisms have been proposed to explain the secretory action of laxative compounds in the intestine: 1. increase of the intracellular amount of cyclic adenosine monophosphate due to stimulation of the adenylate cyclase system and 2. inhibition of intestinal transfer processes, in particular the Na,K-ATPase activated sodium absorption. In a set of in vivo and in vitro experiments in rat colon it could be demonstrated that dihydroxy bile acids (deoxycholate) and diphenolic laxatives (oxyphenisatin) enhance the hydraulic permeability of the mucosal tissue. The permeability changes take place--and there is good experimental evidence--at the zonulae occludentes which bind the epithelial cel…

medicine.medical_specialtyColonSodiummedicine.medical_treatmentHydrostatic pressureLaxativechemistry.chemical_elementStimulationPermeabilitychemistry.chemical_compoundInternal medicineDrug DiscoveryElectrochemistrymedicineStarling equationAnimalsCyclic adenosine monophosphateIntestinal MucosaGenetics (clinical)Adenosine TriphosphatasesTight junctionCatharticsSodiumOxyphenisatin AcetateGeneral MedicineRatsEndocrinologychemistryPotassiumBiophysicsMolecular MedicineFiltrationIntracellularDeoxycholic AcidKlinische Wochenschrift
researchProduct

Mesalazine for the treatment of inflammatory bowel disease

2013

Ulcerative colitis (UC) and Crohn's disease (CD) represent a chronic inflammatory condition of the bowel that often require lifelong medical therapy for the induction and maintenance of the remission. Mesalazine therapies are available both as oral delayed-release and sustained-release formulation, topical formulations and as prodrug.Available literature regarding mesalazine is extensively reviewed in this article, covering its mechanism of action, pharmaceutics and pharmacokinetics, clinical efficacy, safety and tolerability in different settings.Mesalazine has a well-established role in the management of UC. It is the treatment of choice in active and inactive mild-to-moderate UC combinin…

medicine.medical_specialtyColorectal cancerDiseaseGastroenterologyInflammatory bowel diseasechemistry.chemical_compoundCrohn DiseaseMesalazineInternal medicineSecondary PreventionmedicineHumansPharmacology (medical)Intestinal MucosaColitisMesalaminePharmacologyCrohn's diseasebusiness.industryAnti-Inflammatory Agents Non-SteroidalGeneral Medicinemedicine.diseaseUlcerative colitischemistryTolerabilityColitis UlcerativeColorectal NeoplasmsbusinessExpert Opinion on Pharmacotherapy
researchProduct

Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study.

2021

BackgroundSurvivors of childhood cancer are at risk of subsequent primary neoplasms (SPNs), but the risk of developing specific digestive SPNs beyond age 40 years remains uncertain. We investigated risks of specific digestive SPNs within the largest available cohort worldwide.MethodsThe PanCareSurFup cohort includes 69 460 five-year survivors of childhood cancer from 12 countries in Europe. Risks of digestive SPNs were quantified using standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence.Results427 digestive SPNs (214 colorectal, 62 liver, 48 stomach, 44 pancreas, 59 other) were diagnosed in 413 survivors. Wilms tumour (WT) and Hodgkin lymphoma (HL) survivors…

medicine.medical_specialtyColorectal cancerPopulation03 medical and health sciences0302 clinical medicineInternal medicineEpidemiology of cancerCOLORECTAL CANCER SCREENINGmedicineCumulative incidence030212 general & internal medicineGastrointestinal cancerFamily historyeducation610 Medicine & healthGASTROINTESTINAL CANCERCOLORECTAL CANCEReducation.field_of_studybusiness.industryIncidence (epidemiology)Gastroenterologymedicine.disease030220 oncology & carcinogenesisCohortCANCER EPIDEMIOLOGYbusiness360 Social problems & social servicesGut
researchProduct

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (…

2015

ABSTRACT The DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) aims to provide recommendations for definitions of time-to-event end points in cancer randomized controlled trials. We relied on a consensus method based on a multidisciplinary panel of experts to develop these guidelines for trials on sarcomas and gastrointestinal stromal tumors. Background The use of potential surrogate end points for overall survival, such as disease-free survival (DFS) or time-to-treatment failure (TTF) is increasingly common in randomized controlled trials (RCTs) in cancer. However, the definition of time-to-event (TTE) end points is rarely precise and lacks unif…

medicine.medical_specialtyConsensusTime FactorssarcomaDelphi TechniqueEndpoint Determination[SDV]Life Sciences [q-bio]Disease-Free Survivallaw.invention03 medical and health sciencesgastrointestinal stromal tumors0302 clinical medicineRandomized controlled trialSDG 3 - Good Health and Well-beinglawMultidisciplinary approachTerminology as TopicmedicineHumansMedical physicsTreatment Failureguidelinestime-to-event end pointComputingMilieux_MISCELLANEOUSRandomized Controlled Trials as Topic030304 developmental biologyEvent (probability theory)0303 health sciencesEnd pointGiSTSurrogate endpointbusiness.industryefficacy measureCancerHematologymedicine.disease3. Good healthOncologyResearch Design030220 oncology & carcinogenesisrandomized controlled trialDisease ProgressionRadiologySarcomabusiness
researchProduct

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNI…

2020

International audience; Introduction - Patients treated for malignancy are considered at risk of severe COVID-19. This exceptional pandemic has affected countries on every level, particularly health systems which are experiencing saturation. Like many countries, France is currently greatly exposed, and a complete reorganization of hospitals is ongoing. We propose here adaptations of diagnostic procedures, therapies and care strategies for patients treated for digestive cancer during the COVID-19 epidemic. Methods - French societies of gastroenterology and gastrointestinal (GI) oncology carried out this study to answer two main questions that have arisen (i) how can we limit high-risk situat…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralDigestive cancerMEDLINEAntineoplastic AgentsFrench Clinical Practice Guidelines[SDV.CAN]Life Sciences [q-bio]/CancerComorbidityMalignancyBetacoronavirus03 medical and health sciences0302 clinical medicineHealth carePandemicDisease Transmission InfectiousHumansChemotherapyMedicineInfection controlIntensive care medicinePandemicsDigestive System Surgical ProceduresSocieties MedicalGastrointestinal NeoplasmsInfection ControlHepatologySARS-CoV-2business.industryGastroenterologyCOVID-19Evidence-based medicinemedicine.diseaseComorbidityPatient Care ManagementCOVID-19 infection3. Good health030220 oncology & carcinogenesisSurgery030211 gastroenterology & hepatologyFranceCoronavirus InfectionsbusinessDigestive and Liver Disease
researchProduct

Hydro-MRT in der Darmdiagnostik bei Kindern

2001

Purpose A clinical evaluation of hydro-MRI as an alternative method to barium studies in children with abdominal pain of unknown origin is presented. Patients and methods 20 children with abdominal pain of unknown origin aged from 9 - 16 years were examined after oral bowel opacification using 1000 ml of 2.5 % mannitol solution with a 1.0 T MRI system. The investigation was done in 2 planes (coronal and axial) under breath-hold conditions. Imaging procedures included various sequences (T2W HASTE + FS, contrast-enhanced T1W FLASH FS). Suspicious findings in bowel segments and extra-intestinal changes were assessed. Results In 21/24 examinations the small bowel was completely visualized, in 1…

medicine.medical_specialtyCrohn's diseaseAbdominal painConstipationbusiness.industryPleural effusionmedicine.diseaseGastroenterologymedicine.anatomical_structureInternal medicineCoronal planeAscitesmedicineRadiology Nuclear Medicine and imagingLarge intestineRadiologymedicine.symptombusinessPathologicalRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Cytomegalovirus Pneumonia: A Possible Cause of Death in Patients With Crohn's Disease

2013

.

medicine.medical_specialtyCrohn's diseaseGastrointestinal agentCytomegalovirus pneumoniaHepatologyCrohn diseasebusiness.industryGastroenterologymedicine.diseaseCytomegalovirus Cytomegalovirus Infections ColitisGastroenterologyCytomegalovirus pneumonia Crohn’s diseaseAntibodies monoclonalInternal medicinemedicineIn patientbusinessCause of deathAmerican Journal of Gastroenterology
researchProduct

Diagnostic Significance of Epithelioid Granulomas in Crohnʼs Disease in Children

1990

Out of 528 children with Crohn's disease in a Multicenter Paediatric Crohn's Disease Study Group, 37 cases had epithelioid granulomas but did not fulfill defined radiographic criteria of the disease. Follow-up studies including clinical, biochemical, radiological, endoscopic, and histological investigations were done in these patients. Initially, all patients showed clinical symptoms and 27 of them had biochemical signs of chronic inflammation. After a mean follow-up of 3 years, all 37 children treated for Crohn's disease got a complete upper gastrointestinal series with small bowel followthrough and 8 children in addition had barium enemas. Colonoscopies were done in 23 patients. Radiograp…

medicine.medical_specialtyCrohn's diseasemedicine.diagnostic_testUpper gastrointestinal seriesbusiness.industryGastroenterologyDiseasemedicine.diseaseDermatologyGastroenterologydigestive system diseasesChronic granulomatous diseaseInternal medicineGranulomaPediatrics Perinatology and Child HealthBiopsymedicinebusinessEpithelioid cellBarium enemaJournal of Pediatric Gastroenterology and Nutrition
researchProduct

Effects of nicotine receptor agonists on acetylcholine release from the isolated motor nerve, small intestine and trachea of rats and guinea-pigs

1992

The effects of nicotine receptor agonists on the release of [3H]acetylcholine from the phrenic nerve, the small intestine and the trachea were investigated to characterize neuronal nicotine receptors within the peripheral nervous system. Contraction of the indirectly-stimulated hemidiaphragm was recorded to investigate desensitization of the postsynaptic muscular nicotine receptors. Nicotine, cytisine, 1,1-dimethyl-4-phenylpiperazinium and 2-(4-aminophenyl)-ethyl-trimethyl-ammoniumiodide caused a concentration-dependent (0.1-30 microM) increase in evoked [3H]acetylcholine release from the phrenic nerve, whereby bell-shaped concentration-response curves were obtained. The rank order of decre…

medicine.medical_specialtyDiaphragmGuinea PigsMyenteric PlexusMotor nerveReceptors NicotinicMotor EndplateNicotineCytisinechemistry.chemical_compoundPostsynaptic potentialInternal medicineIntestine SmallDrug DiscoverymedicineAnimalsGenetics (clinical)Phrenic nerveDose-Response Relationship DrugMuscle SmoothGeneral MedicineAcetylcholineStimulation ChemicalRatsPhrenic NerveTracheaEndocrinologymedicine.anatomical_structureParasympathomimeticschemistryPeripheral nervous systemMolecular Medicinemedicine.symptomSecretory RateAcetylcholineMuscle Contractionmedicine.drugMuscle contractionThe Clinical Investigator
researchProduct

Hyperammonemic encephalopathy after urinary diversion. Diet therapy

2016

medicine.medical_specialtyDiet therapymedicine.medical_treatment030232 urology & nephrologyUrinary DiversionPlant Proteins DietaryGastroenterologyIntestinal absorption03 medical and health sciencesEpilepsy Complex Partial0302 clinical medicineAmmoniaInternal medicinemedicineHumansHyperammonemia030212 general & internal medicineAgedAcidosisCarcinoma Transitional CellCARCINOMA TRANSITIONAL CELLBrain Diseases Metabolicbusiness.industryUrinary diversionHyperammonemiaHydrogen-Ion Concentrationmedicine.diseaseSurgeryIntestinal AbsorptionUrinary Bladder NeoplasmsFemaleDietary Proteinsmedicine.symptomAcidosisHyperammonemic encephalopathybusinessEndocrinología y Nutrición (English Edition)
researchProduct